Mutant RAS proteins drive the progression of some of the deadliest cancers, including nearly all pancreatic cancers, half of colorectal cancers, and one-third of lung cancers. These mutant proteins ...

Clorinda Schettino, Division of Medical Oncology ... and 160,390 cancer-related deaths in the USA in 2007. Non-small-cell lung cancer (NSCLC) accounts for approximately 80% of all lung cancers.

In closing its therapeutics division and laying off 200 people, 23andMe ended an audacious bet it made nearly a decade ago — ...

Highlights include acalabrutinib’s approval for mantle cell lymphoma, T-DXd’s priority review for HER2-low breast cancer, advances in MDS, TNBC, HCC, and perioperative lung cancer research ... of ...

Scientists have discovered a way to target elusive circular fragments of DNA that drive the survival of some of the most aggressive cancers, paving the way for future treatments.

By morning, a heavy layer of fog blanketed the city, reducing visibility to as low as 125 metres in certain areas, says IMD official ...

Optune Lua creates tumor-treating fields to disrupt cancer cell division, and it is used in conjunction with PD-1/PD-L1 inhibitors or docetaxel to treat metastatic non–small cell lung cancer ...

Delhi's annual average PM10 and PM2.5 levels were higher by 5 per cent and 7 per cent, respectively, between January 1 and November 12 against the year-ago period, the latest CPCB data showed on ...

Certain mutations can be "drivers" of your lung cancer. That means they’re the main cause of your cancer growth and cell division. Epidermal growth factor receptor (EGFR) mutation is one ...

Over a decade of exposure, these mutations are often linked to genes that play a key role in regulating cell division, ...